News
)
14 August 2023
Contribution to an article defining the benefits of lentiviruses in BioPharm International
In a recent article in BioPharm International, Chris Spivey speaks about different types of viral vectors that are regularly used in gene therapy, each with...
Read more)
17 July 2023
VIVEbiotech participates in the XVI Annual Biotechnology Congress
Soledad Baños-Mateos, senior researcher of the Department of Technological Innovation of VIVEbiotech, has participated in the XVI Congreso Anual de Biotecnología (BAC Badajoz 2023)...
Read more)
11 July 2023
VIVEbiotech contributes to accelerate the development of muscular dystrophies through the European MAGIC project
VIVEbiotech is a CDMO GMP that develops and manufactures lentiviral vectors from early stage to commercial scale. It is currently working on more than 40 international...
Read more)
19 June 2023
VIVEbiotech interview on C> manufacturing trends at Drug Discovery World
VIVEbiotech participated in the ISCT, International Society for Cell & Gene Therapy´s (ISCT) Annual Meeting took place three weeks ago in beautiful Paris.
Read more)
13 June 2023
Gurutz Linazasoro, CEO of VIVEbiotech, participates in the Foro de Biociencia
Gurutz Linazasoro, CEO of VIVEbiotech, will participate tomorrow in a round table discussion entitled "Boosting science and research of high quality and impact" at the...
Read more)
4 June 2023
VIVEbiotech has successfully participated in 5 international congresses in the first half of the year
VIVEbiotech has successfully participated in 5 international congresses in the first half of the year.
Read more)
18 May 2023
Article in RegMedNet about lentiviral vectors development and manufacturing challenges
Natalia Elizalde was interviewed at the Phacilitate's Advanced Therapies Week that took place in Miami in January this year.
Read more)
18 May 2023
VIVEbiotech collaborates with Gyros Protein Technologies in two Gyrolab Technology Seminars
Bárbara Rodríguez-Urretavizcaya, Analytical Development Scientist, has presented at two Gyrolab Technology Seminars.
Read more)
10 March 2023
Video-interview by The Medicine Maker
Natalia Elizalde was video-interviewed by The Medicine Maker during Phacilitate´s Advanced Therapies Week that took place in Miami in January.
Read more)
2 March 2023
Scrip reports on the predictions of VIVEbiotech
Natalia Elizalde has been included in the clinical trial section about the leading annual article series by Scrip alongside a number of leading international figures...
Read moreDestacadas
)
)
)
)
4 December 2024
)
)
)
)
)
)